Orencia and Thrombocytopenia aggravated - a phase IV clinical study of FDA data
We study 124,994 people who have side effects when taking Orencia. Thrombocytopenia aggravated is found, especially among people who are female, 50-59 old, have been taking the drug for 1 - 6 months, also take Enbrel and have Pain.
The phase IV clinical study analyzes which people take Orencia and have Thrombocytopenia aggravated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
124,994 people reported to have side effects when taking Orencia.
Among them, 745 people (0.6%) have Thrombocytopenia aggravated.
What is Orencia?
Orencia has active ingredients of abatacept. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 125,318 Orencia users.
What is Thrombocytopenia aggravated?
Thrombocytopenia aggravated (worse decrease of platelets in blood) is found to be associated with 2,162 drugs and 688 conditions by eHealthMe. Currently, we are studying 289 people who have Thrombocytopenia aggravated.
Number of Orencia and Thrombocytopenia aggravated reports submitted per year:
Time on Orencia when people have Thrombocytopenia aggravated *:
Gender of people who have Thrombocytopenia aggravated when taking Orencia*:
Age of people who have Thrombocytopenia aggravated when taking Orencia *:
Common drugs people take besides Orencia *:
Common side effects people have besides Thrombocytopenia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Orencia and have Thrombocytopenia aggravated?Check whether Thrombocytopenia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Orencia side effects by duration, gender and age:
- Orencia side effects (125,318 reports)
Thrombocytopenia aggravated treatments and more:
- Thrombocytopenia aggravated (289 reports)
Common drugs associated with Thrombocytopenia aggravated:
- Revlimid: 14,996 reports
- Prednisone: 12,604 reports
- Aspirin: 11,527 reports
- Cyclophosphamide: 10,264 reports
- Dexamethasone: 10,095 reports
- Carboplatin: 9,099 reports
- Methotrexate: 9,005 reports
- Omeprazole: 8,175 reports
- Allopurinol: 8,019 reports
- Furosemide: 7,751 reports
All the drugs that are associated with Thrombocytopenia aggravated:
- Thrombocytopenia aggravated (2,162 drugs)
Common conditions associated with Thrombocytopenia aggravated:
- Multiple myeloma: 19,704 reports
- High blood pressure: 9,472 reports
- Hepatitis c: 5,620 reports
- Pain: 5,350 reports
- Rheumatoid arthritis: 4,906 reports
- Primary myelofibrosis: 4,843 reports
All the conditions that are associated with Thrombocytopenia aggravated:
- Thrombocytopenia aggravated (688 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on abatacept (the active ingredients of Orencia) and Orencia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cotazym and Sleep Apnea Syndrome - 18 seconds ago
- Clindamycin Hydrochloride and Novolin N drug interaction - 20 seconds ago
- Lamisil and Zanaflex drug interaction - 24 seconds ago
- Sinemet Cr and Gastroesophageal Reflux Disease - 39 seconds ago
- Nasonex and Sprintec drug interaction - 42 seconds ago
- Dimenhydrinate and Metronidazole drug interaction - a minute ago
- Ruxience and Tadalafil drug interaction - a minute ago
- Sertraline Hydrochloride and Abilify drug interaction - 2 minutes ago
- Clopra and Ultram drug interaction - 2 minutes ago
- Actifed and Methotrexate drug interaction - 3 minutes ago